Eden Research (EDEN)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3.90p
   
  • Change Today:
      0.100p
  • 52 Week High: 6.25p
  • 52 Week Low: 3.50p
  • Currency: UK Pounds
  • Shares Issued: 533.35m
  • Volume: 1,494,153
  • Market Cap: £20.80m

Latest ShareCast News

Eden Research product granted temporary approval in Greece

By Josh White

Date: Monday 02 Sep 2024

(Sharecast News) - Sustainable biopesticide developer Eden Research announced on Monday that its Cedroz product has been granted temporary approval in Greece for the 2024 growing season.

Eden Research revenue set to beat market expectations

By Josh White

Date: Monday 22 Jan 2024

(Sharecast News) - Biopesticide specialist Eden Research said in a trading update on Monday that it expected a 72% increase in full-year revenue for 2023, to £3.1m, surpassing market expectations by £0.3m.

Eden Research bird repellant gets temporary approval in Italy

By Josh White

Date: Monday 18 Dec 2023

(Sharecast News) - Eden Research and Corteva Agriscience announced the temporary approval of Ecovelex 2023 in Italy on Monday for use as a bird-repellent seed treatment in corn during the 2024 growing season.

Eden Research applies for Ecovelex approval in t... 03-Jul-2023 ShareCast
Eden Research inks deal with Colombia distributor 15-Jun-2023 ShareCast
Sunday share tips: Eden Research, Lok'nStore 04-Jun-2023 ShareCast
Eden Research gets product approvals in Californ... 12-May-2023 ShareCast
Eden Research losses narrow as it expands produc... 05-May-2023 ShareCast
Eden Research set to beat expectations for reven... 10-Jan-2023 ShareCast
Eden Research inks distribution deal with Cortev... 15-Dec-2022 ShareCast
Eden Research first-half loss set to narrow to £... 22-Aug-2022 ShareCast
Director dealings: Finance chiefs buy shares at ... 31-May-2022 ShareCast
Eden Research makes regulatory progress in US, I... 10-May-2022 ShareCast
Eden Research gets label extension for biofungic... 26-Aug-2021 ShareCast
Eden Research gets new product approvals in Moro... 05-Jul-2021 ShareCast
Eden Research signs exclusive deal with Corteva ... 12-May-2021 ShareCast
Eden Research's 'Cedroz' gets approval in Italy 10-May-2021 ShareCast
Eden Research partner in Spain gets authorisatio... 31-Mar-2021 ShareCast
Eden Research losses widen as revenues slip amid... 11-Feb-2021 ShareCast
Eden Research gets more approvals in France and ... 17-Sep-2020 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Eden Research Market Data

Currency UK Pounds
Share Price 3.90p
Change Today 0.100p
% Change 2.63 %
52 Week High 6.25p
52 Week Low 3.50p
Volume 1,494,153
Shares Issued 533.35m
Market Cap £20.80m

Eden Research Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
14.4% below the market average14.4% below the market average14.4% below the market average14.4% below the market average14.4% below the market average
20% below the sector average20% below the sector average20% below the sector average20% below the sector average20% below the sector average
Price Trend
47.83% below the market average47.83% below the market average47.83% below the market average47.83% below the market average47.83% below the market average
6.12% above the sector average6.12% above the sector average6.12% above the sector average6.12% above the sector average6.12% above the sector average
Income Not Available
Growth
53.19% above the market average53.19% above the market average53.19% above the market average53.19% above the market average53.19% above the market average
52.94% above the sector average52.94% above the sector average52.94% above the sector average52.94% above the sector average52.94% above the sector average

Eden Research Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
15:54 137,044 @ 3.89p
15:54 146,222 @ 3.89p
15:39 240,000 @ 3.90p
13:26 130,000 @ 3.90p
13:26 150,000 @ 3.85p

Eden Research Key Personnel

CFO Alexander John Abrey
CEO Sean M. Smith

Top of Page